
OrganiGram Holdings OGI
$ 1.5
4.55%
Annual report 2024
added 12-27-2025
OrganiGram Holdings Cash Conversion Cycle 2011-2026 | OGI
Annual Cash Conversion Cycle OrganiGram Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 2.92 K | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.92 K | 2.92 K | 2.92 K |
Cash Conversion Cycle of other stocks in the Drug manufacturers industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
-38 | - | 7.5 % | $ 6.35 M | ||
|
Agile Therapeutics
AGRX
|
-206 | - | 10.11 % | $ 58.2 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M | ||
|
Catalent
CTLT
|
110 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
41.4 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | ||
|
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | ||
|
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
192 | - | - | $ 2.06 B | ||
|
Cumberland Pharmaceuticals
CPIX
|
-161 | $ 3.09 | -2.83 % | $ 43.4 M | ||
|
Cronos Group
CRON
|
213 | $ 2.67 | 3.89 % | $ 1.38 B | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
Jupiter Wellness
JUPW
|
-206 | - | - | $ 33.6 M | ||
|
Bausch Health Companies
BHC
|
78.9 | $ 5.73 | 0.79 % | $ 2.09 B | ||
|
Harrow Health
HROW
|
18.3 | $ 38.19 | 0.64 % | $ 1.4 B | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 3.69 | 4.53 % | $ 86.3 M | ||
|
Canopy Growth Corporation
CGC
|
177 | $ 1.15 | 5.05 % | $ 124 M | ||
|
Tilray
TLRY
|
169 | $ 6.82 | -1.37 % | $ 4.21 B | ||
|
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | ||
|
Veru
VERU
|
6.7 | $ 2.45 | 2.08 % | $ 330 M | ||
|
Viatris
VTRS
|
155 | $ 13.82 | -0.68 % | $ 16.6 B | ||
|
Evolus
EOLS
|
74.8 | $ 4.46 | 0.45 % | $ 288 M | ||
|
Emergent BioSolutions
EBS
|
181 | $ 8.71 | 0.52 % | $ 446 M | ||
|
Organogenesis Holdings
ORGO
|
64.5 | $ 2.56 | 2.03 % | $ 337 M | ||
|
Pacira BioSciences
PCRX
|
209 | $ 23.38 | -1.56 % | $ 1.08 B | ||
|
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | ||
|
ProPhase Labs
PRPH
|
96 | - | - | $ 5.07 M | ||
|
cbdMD
YCBD
|
92 | $ 0.73 | 0.27 % | $ 3.15 M | ||
|
Assertio Holdings
ASRT
|
467 | $ 18.02 | - | $ 115 M | ||
|
Radius Health
RDUS
|
-53.5 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
314 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
106 | $ 1.13 | 10.29 % | $ 56.4 M | ||
|
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
150 | $ 2.27 | 4.13 % | $ 2.82 M | ||
|
Zomedica Corp.
ZOM
|
154 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
57 | $ 0.87 | -6.54 % | $ 31.3 M | ||
|
China Pharma Holdings
CPHI
|
139 | $ 0.65 | 5.21 % | $ 2.79 M | ||
|
TherapeuticsMD
TXMD
|
-723 | $ 2.16 | 2.37 % | $ 25 M |